颅脑微创血肿清除术治疗高血压性脑出血的临床研究

Clinical Study on the Treatment of Hypertensive Cerebral Hemorrhage by Minimally Invasive Hematoma Removal

目的探讨颅脑微创血肿清除术在高血压性脑出血治疗中的价值。方法回顾性分析贵州省黔西南州人民医院2019年1月至12月收治的80例高血压性脑出血患者的临床资料,按不同治疗方法分为研究组和对照组,每组40例。研究组采用颅脑微创血肿清除术,对照组采用常规治疗,比较两组患者的治疗有效率、预后情况、血肿量及症状消失时间。结果研究组患者格拉斯哥结局评分(GOS)分级中V级患者20例,对照组V级患者仅有10例,两组患者预后情况对比,差异有统计学意义(P<0.05),且研究组Ⅲ-Ⅴ级患者34例,占比85.00%,对照组仅有30例,占比75.00%;血肿量、临床症状消失时间对比研究组优于对照组(P<0.05)。结论颅脑微创血肿清除术应用于高血压性脑出血治疗效果确切,有效率高,可显著改善患者的症状,提高预后质量、减少血肿,值得临床推广使用。

Objective To explore the value of minimally invasive evacuation of hematoma in the treatment of hypertensive intracerebral hemorrhage.Methods The clinical data of 80 patients with hypertensive intracerebral hemorrhage treated in Qianxinan people’s Hospital from January to December 2019 were retrospectively analyzed,and they were divided into study group and control group according to different treatment methods,with 40 cases in each group.The study group was treated with minimally invasive craniocerebral hematoma clearance,while the control group was treated with conventional treatment.The effective rate,prognosis,hematoma volume and symptom disappearance time of the two groups were compared.Results He Glasgow Outcome Scale(GOS)grade V patients in the study group were 20 cases,the control group was only 10 cases of grade Ⅴ patients,the difference was statistically significant(P<0.05),and the study group Ⅲ-Ⅴ patients in 34 cases,accounting for 85.00%,the control group only 30 cases,accounting for 75.00%;hematoma volume,clinical symptoms disappeared time,the study group was better than the control group(P<0.05).Conclusion Minimally invasive craniocerebral hematoma removal in the treatment of hypertensive intracerebral hemorrhage has exact effect and high effective rate.It can signifiesntly improve the symptoms of patients,improve the quality of prognosis and reduce hematoma.